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Highlights 
 Plasma procalcitonin (PCT) level was evaluated in healthy calves and those with septic 
systemic inflammatory response syndrome (SIRS). 
 Plasma PCT concentration was higher in the septic SIRS group than in the healthy group. 
 An increase in PCT concentration in the septic SIRS group was confirmed, as in humans 
and other species. 
 PCT could be used as marker for septic SIRS in calves. 
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Abstract 
The diagnosis of sepsis in calves is challenging. Blood culture and clinical signs 
combined with a complete blood count have been used for the diagnosis of sepsis. Recent 
literature in humans and animal species has been focused on sepsis-specific biomarkers, such 
as procalcitonin (PCT), that may more accurately and efficiently diagnose sepsis. The aim of 
this study was to evaluate plasma PCT concentrations in healthy and septic calves. Twenty 
healthy control calves and 58 sick calves with septic systemic inflammatory response 
syndrome (SIRS) based on SIRS score and clinical findings were included. Calves with 
septic SIRS were further divided in septic SIRS survivors (SSS) and non-survivors (SSNS). 
Plasma PCT concentrations were measured with a commercial ELISA assay for cattle. A 
receiver operating characteristic curve was used to determine cut-off values and 
corresponding sensitivity and specificity for the diagnosis of sepsis. Differences in plasma 
PCT concentration between groups (control vs. SSS vs. SSNS) were evaluated. 
 
Plasma PCT concentrations in healthy calves and those with septic SIRS were 33.3 
pg/mL (0 - 44.3 pg/mL) and 166.5 pg/mL (85.9 - 233.0 pg/mL), respectively (P<0.001). The 
optimal cut-off value to predict septic SIRS was 67.39 pg/mL (81.0% sensitivity, 95.0% 
specificity). Plasma PCT concentrations were 127.4 pg/mL (72.2 – 216.0 pg/mL) and 234.3 
pg/mL (204.5 – 309.4 pg/mL) in the SSS and SSNS subgroups, respectively. Statistically 
significant differences were found among groups (control vs. SSS and SSNS, P<0.0001; SSS 
vs. SSNS, P >0.05). These results confirmed an increase in plasma PCT concentrations in 
calves with septic SIRS, as previously reported in humans and other species.  
 
Keywords: Calves; Diagnostic test; Procalcitonin; Sepsis; Systemic inflammatory response 
syndrome 
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Introduction 
Since the American College of Chest Physicians/Society of Critical Care Medicine 
Consensus Conference in 1991, the term sepsis has been defined as the ‘systemic 
inflammatory response to infection’ (Bone et al., 1992). The expression ‘systemic 
inflammatory response syndrome’ (SIRS) describes a clinical condition that represents the 
culmination of the activation of a complex network of acute endogenous mediators, which 
lead to uncontrolled and widespread inflammation (Alberti et al., 2005). SIRS can be 
associated with many different factors, including hypoxia, burns, trauma, immunologic 
reactions, bacterial and viral infections (Bone et al., 1992; Alberti et al., 2005). Confirmation 
of microbial infection in the presence of SIRS is required for a diagnosis of sepsis (Zabrecky 
et al., 2015).  
 
Sepsis in calves is either sporadic or epidemic, reaching a prevalence of 30% if 
predisposing factors for the development of neonatal septicemia are present (Aldrige et al., 
1993; Fecteau et al., 2009). Many factors predispose calves to sepsis, such as failure of 
passive transfer, management deficits, adverse environmental conditions, cold stress, protein-
energy malnutrition, micronutrient deficiencies, or bacterial colonization of a local site, such 
as the umbilicus, gastro-intestinal tract or respiratory system (House et al., 2015). The 
pathophysiologic changes associated with inflammatory activation in sepsis are dehydration 
and alterations in heart rate, respiratory rate, body temperature, mucous membrane status and 
capillary refill time, as well as leukopenia, hypotension and generalized weakness (House et 
al., 2015). The definitive diagnosis of sepsis is based on a blood culture. However, the 
sensitivity of blood culture can be low and a negative result must be interpreted with caution 
(Fecteau et al., 2009). In veterinary medicine, clinical signs combined with a complete blood 
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count (CBC) and scores are considered useful in the diagnosis of sepsis. However, sepsis-
specific biomarkers have become a recent focus of research in both humans and veterinary 
species because they could potentially increase diagnostic accuracy and efficiency (Fecteau et 
al., 2009; Fielding and Magdesian, 2015; Ercan et al., 2016).  
 
Procalcitonin (PCT) has been investigated as a biomarker of sepsis in humans (Riedel, 
2012; Deliberato et al., 2013; Afsar and Sener, 2015), and in horses (Toribio et al., 2003; 
Pusterla et al., 2006; Rieger et al., 2014; Bonelli et al., 2015a; Bonelli et al., 2015b; Barton et 
al., 2016; Bonelli et al., 2017), cattle (Ercan et al., 2016) and dogs (Giunti et al., 2006; 
Yilimaz et al., 2008). Healthy individuals have very low serum PCT concentrations due to the 
restriction of the CALC-I gene transcription by the neuroendocrine cells in the thyroid gland 
and in the lungs (Riedel, 2012; Afsar and Senar, 2015). The expression of the CALC-I gene 
is up-regulated in many cell types in septic humans (Riedel, 2012; Afsar and Senar, 2015) 
and in septic animals (Toribio et al., 2003; Giunti et al., 2010); thus, PCT is released into the 
circulation from many cell types. In septic human patients, PCT rises rapidly (within 3-6 h) 
and decreases by half within 24 h when the infection and/or host immune response is 
controlled (Riedel, 2012; Afsar and Senar, 2015). PCT also remains stable in blood 
specimens at room temperature, unlike other markers of sepsis (Carrol et al., 2002). In 
veterinary medicine, studies have reported plasma PCT concentrations in septic and non-
septic foals (Bonelli et al., 2015a), adult horses (Rieger et al., 2014; Bonelli et al., 2015b; 
Bonelli et al., 2017), and dogs (Giunti et al., 2006; Yilmaz et al., 2008). The aim of this study 
was to evaluate and compare plasma PCT concentrations in healthy and septic calves.  
 
Materials and methods 
Animals 
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This in vivo multicentric experimental trial was conducted in a clinical setting and 
was approved by the Italian Animal Care (DL 116/92) and by the Institutional Animal Care 
and Use Committees of the University of Pisa (Approval Number 2825; Approval Date 28 
January, 2014) and the University of Milan (Approval Number 2; Approval Date 15 
February, 2016). At Cornell University, residual blood from specimens routinely collected 
from calves on hospital admission was used. Written consent was obtained from the owners 
of all calves included.  
 
During the research period, a total of 260 calves were admitted to the veterinary 
teaching hospitals involved in the study. However, the authors excluded cases that did not fit 
the inclusion criteria, resulting in the inclusion of 78 calves aged 9.6±4.3 days. Twenty of 78 
were healthy Holstein calves (n=11/20 females and n=9/20 males) aged 8.4±3.9 days and 
were housed at the university dairy farm of the University of Pisa. Fifty-eight of 78 (n=35/58 
females and n=23/58 males), aged 10.6±4.2 days, were sick, client-owned calves referred to 
three participating veterinary teaching hospitals providing secondary health care (the 
Veterinary Teaching Hospital ‘M. Modenato’, University of Pisa, Italy; the ‘Nemo’ Farm 
Animal Hospital, Cornell University, Ithaca, NY, USA; the Clinic for Ruminants and Swine, 
University of Milan, Italy). Sick calves were Holstein Friesian (n=50/58) or mixed dairy 
breeds (n=8/58).  
 
Collection of clinical and clinical pathological data 
A complete history was recorded, when possible, for each calf at admission time, 
especially information concerning previous antimicrobial treatment. All calves were 
subjected to a complete physical examination and blood was collected for CBC with 
differential white cell count and blood culture at admission time. Calves needed only manual 
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restraint for all procedures. A 1 mL blood sample for CBC was collected from the jugular 
vein in an EDTA tube (FL Medical) and analyzed by a cell counter (ProCyte Dx, IDEXX) 
within 5 min of collection. The EDTA blood was also used for blood smears, which were air-
dried and stained using an automatic stainer (Aerospray 7150 Hematology Slide Stain-
Cytocentriguge). The differential white cell count was performed by microscopic 
examination at 400 u and 1000 u magnification, counting 100 cells. A sample for blood 
culture was collected aseptically and a commercial culture system (OXOID SIGNAL Blood 
Culture System, Oxoid) was used as previously reported (Daley et al., 1990; Rohner et al., 
1995). The outcome was recorded for all the sick client-owned calves as ‘discharged’ or 
‘died/euthanased’. 
 
Inclusion criteria 
Calves < 3 weeks old were enrolled. Each calf was scored according to a SIRS scale 
as previously described (Trefz et al., 2016). Only calves with a positive SIRS score were 
included in the septic SIRS group. SIRS positivity was based on the presence of two or more 
of the following criteria (Trefz et al., 2016): (1) presence of an abnormal leucocyte count, i.e. 
leukopenia or leukocytosis (reference interval, 5–12 × 109/L); (2) hyperthermia or 
hypothermia (reference interval, 38.5– 39.5 °C); (3) tachycardia (> 120 beats/min); and (4) 
tachypnea (> 36 breaths/min). Calves with SIRS were considered septic if there was clinical 
or necropsy evidence of septicemia (Lofstedt et al., 1999). In particular, the ante-mortem 
criteria were as follows: (1) positive blood culture; (2) culture of the same bacterial agent 
from at least two body fluids; or (3) culture of a bacterial agent from a single joint in a calf 
with joint effusion involving multiple joints. The post-mortem criteria were as follows: (1) 
morphologic changes, such as multiple disseminated abscesses of similar size, purulent 
vasculitis and intravascular identification of bacteria, or fibrin in multiple body cavities; (2) 
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bacterial isolation from heart blood; or (3) recovery of the same bacterial isolate from at least 
two tissues (excluding intestine). No calves included in the control group had any signs of 
SIRS (SIRS score, 0), or clinical signs of septicemia. 
 
Evaluation of plasma PCT concentration 
A 2.5 mL aliquot was collected at admission time in heparinized tubes (FL Medical) 
and immediately centrifuged at 2.100 g for 10 min. The harvested plasma was placed in 
sterile tubes, frozen at -18 °C, and analyzed for PCT in a single batch within 3 months. The 
concentrations of PCT were determined using a commercial kit for cattle (Bovine 
Procalcitonin ELISA kit, MyBiosource.com). The intra-assay coefficient of variation was 
determined from 10 replicates of calf plasma samples with known low and high PCT 
concentrations. These samples were obtained by adding standard amounts of PCT provided 
with the ELISA kit in blank samples of calf blood. The inter-assay coefficient of variation 
was determined by repeating the analysis of duplicate samples with low and high PCT 
concentrations in five different assays. Samples were measured in 10 replicates in a single 
assay and in five different assays. The intra- and inter-assay coefficient of variations were 
both < 15%; the limit of detection of the method was 10 pg/mL. To establish the detection 
limit for bovine plasma PCT, we performed repeated PCT measurement using bovine 
samples with low PCT concentrations (<10.0 pg/mL).  Results less than the limit of detection 
were expressed as 0. 
 
Statistical analysis 
Kolmogorov-Smirnov tests were applied to verify data distribution. Descriptive data 
are reported as median and 25th/75th percentile for both the control and septic SIRS groups. 
Mann-Whitney U tests for unpaired data were performed to verify differences in plasma PCT 
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concentrations between the healthy controls and the septic SIRS groups. Receiver operating 
characteristic (ROC) analysis was performed to obtain specificity and sensitivity of the test at 
various cutoff values with a confidence interval (CI) of 95%. Likelihood ratio was calculated 
for each cut-off value. Results from animals in the septic SIRS group were further divided in 
two subgroups, depending on the outcome of disease, i.e. whether they recovered (septic 
SIRS survivors subgroup, SSS), or were euthanased or died (septic SIRS non-survivors 
subgroup, SSNS). Kolmogorov-Smirnov tests were applied to verify data distribution for 
plasma PCT concentrations in the SSS and SSNS subgroups. The results did not show a 
Gaussian distribution for plasma PCT concentrations in either subgroup, so descriptive data 
are reported as median and 25th/75th percentile. Kruskal-Wallis tests for unpaired data and 
Dunn’s multiple comparisons post-hoc tests were performed to verify differences in plasma 
PCT concentrations among groups (control vs. SSS vs. SSNS). 
 
Statistical significance was set at P <0.05 and commercial statistics software was used 
(GraphPad Prism 6). 
 
Results 
Collection of a complete history was not possible for every calf included. All 20 
healthy control calves remained healthy for the entire study period. All 58 sick calves had a 
SIRS score ≥2 and clinical or necropsy evidence of septicemia. The most common diagnoses 
in the sick calves were septicemia, pleuritis, pneumonia, diarrhea with signs of dehydration 
and electrolyte imbalance, peritonitis, omphalitis, polyarthritis. Blood cultures were 
performed in five cases (8.6% of all blood cultures were positive). Only E. coli was cultured 
from each of the calves with positive blood culture. Culture of the same pathogen from at 
least two body fluids antemortem (e.g. peritoneal fluid, bronchoalveolar lavage fluid) was 
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used to diagnose 45 cases: E.coli was cultures in 30/45 cases (67%); other bacteria isolated 
were Campylobacter spp. (n=6), Pasteurella haemolytica (n=4), Clostridium spp. (n=3), and 
Enterococcus spp. (n=2). A positive antemortem joint culture from calves with polyarthritis 
was used to diagnose septicemia in two cases. In both cases, E. coli was cultured. Regarding 
post mortem evaluation, morphologic lesions such as multiple abscesses, purulent vasculitis, 
intravascular identification of bacteria, and fibrin exudation in multiple body cavities, were 
present in six calves. All 58 sick calves satisfied the criteria for the diagnosis of septicemia 
and were included in the septic SIRS group.  
 
Plasma PCT concentration was 33.3 pg/mL (0 - 44.3 pg/mL) in the control group and 
166.5 pg/mL (85.9 - 233.0 pg/mL) in the septic SIRS group (Fig.1; P<0.0001). The resulting 
area under the ROC curve was 0.92 (95% CI: 0.86-0.98; P< 0.001; Fig. 2), and the optimal 
cut-off value to differentiate healthy calves from calves critically ill with clinical evidence of 
SIRS and septicemia was 67.39 pg/mL (mean sensitivity 81%, 95% CI, 68%–90%; mean 
specificity value 100%, 95% CI 83% – 100%; Table 1).  
 
 Fifty-two of 58 (89.7%) calves with septic SIRS recovered and were included in the 
SSS subgroup; 5/58 (8.6%) calves with septic SIRS were euthanased on economic grounds, 
and 1/58 (1.7%) died; thus 6/58 calves were included in the SSNS subgroup. Plasma PCT 
concentrations were 127.4 pg/mL (72.2 – 216.0 pg/mL) and 234.3 pg/mL (204.5 – 309.4 
pg/mL) in the SSS subgroup and in the SSNS subgroup, respectively. Kruskal-Wallis tests for 
unpaired data indicated that there were statistically significant differencese in plasma PCT (P 
< 0.001) among the three groups of calves (SSS, SSNS, control).  Post-hoc Dunn’s multiple 
comparisons tests demonstrated differences between the control group and the SSS subgroup 
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(P<0.0001), between the control group and SSNS subgroup (P<0.0001), and between the 
SSS and SSNS subgroups (P<0.02). 
 
Discussion 
Despite the fact that neonatal sepsis is the third most common cause of mortality in 
large animal neonates, early recognition of clinical signs is challenging for farm managers 
and early diagnosis remains challenging for veterinarians (Fecteau et al., 1997; Lofstedt et al., 
1999; House et al., 2015). In the present study, plasma PCT concentrations were statistically 
lower in healthy calves than in calves with septic SIRS. Our results confirmed that plasma 
PCT increases during septic SIRS in calves, as previously reported in the horses, dogs and 
humans (Yilmaz et al., 2008; Riedel, 2012; Rieger et al., 2014; Afsar and Senar, 2015, 
Bonelli et al., 2015a; Bonelli et al., 2015b; Bonelli et al., 2017). Moreover, mean plasma PCT 
concentrations in both healthy calves and those with septic SIRS were similar to those 
reported in horses (Bonelli et al., 2015a; Bonelli et al., 2015b; Bonelli et al., 2017), lower 
than those reported in human newborns (Altunhan et al., 2011) and children (Lacour et al., 
2001), and higher than in dogs (Yilimaz et al., 2008), but these dissimilarities could be 
related to differences in the assays used. The results obtained for the control group were 
similar to those reported for healthy calves by others (Ercan et al., 2014). Recently, Ercan and 
colleagues evaluated some biomarkers for healthy cattle and Ercan et al., 2016 investigated 
the diagnostic value of determining the serum concentrations of PCT and other markers 
(neopterin, tumor necrosis factor alpha, prostaglandin E2, malondialdehyde, interleukin 8 and 
IFN-γ) in neonatal calves diagnosed with septicemic colibacillosis (Ercan et al., 2016). Serum 
PCT concentrations were four times higher in septicemic calves with colibacillosis than in 
healthy calves (Ercan et al., 2016). Plasma PCT concentrations in calves with septic SIRS in 
our study were similar to those described by Ercan and colleagues (2016). However, we 
AC
CE
PTE
D M
AN
US
CR
IPT
 
 
 
included a calves with SIRS and septicemia caused by a variety of conditions, while Ercan 
and colleagues (2016) enrolled only calves with septicemic colibacillosis.  
 
Plasma PCT concentrations were statistically different when the control group was 
compared with the SSS and the SSNS subgroups and plasma PCT concentrations were 
statistically higher in the SSNS subgroup than in the SSS subgroup. This result suggests a 
possible role for plasma PCT in predicting unfavorable outcome in calves with septic SIRS, 
as reported in humans for sepsis, severe sepsis and septic shock (Huang et al., 2016; Ko et al., 
2016; Liu et al., 2016; Poddar et al., 2016). However, the small group size in the SSNS 
subgroup compared to the SSS subgroup limits the conclusions that can be drawn concerning 
case outcome. The prognostic value of plasma PCT should be addressed in future studies. 
 
Our cut-off value for plasma PCT (67.39 pg/mL) to differentiate septic from non-
septic calves is lower than that reported for human adults (Riedel, 2012), neonates and 
children (Lacour et al., 2001; Altunhan et al., 2011), but similar to that reported for foals 
(Bonelli et al., 2015a). To the best of authors’ knowledge, such cut-off values have not 
previously been reported in literature for calves or adult cattle.  
 
 The survival rate in our present study appears to be unusually high for a population of 
septic calves. At admission, few calves were bacteremic, but most had signs of localized 
sepsis. Although historical findings were not available for all cases, some calves had already 
received treatment before presentation to a veterinarian, which might explain the low number 
of calves that died or were euthanased. 
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A limitation of the present study is the low number of blood culture-positive calves. A 
negative blood culture result must be interpreted with caution because many factors can 
interfere with bacterial isolation from blood culture specimens. Prior antibiotic therapy, the 
presence of opsonizing antibodies, low numbers of circulating bacteria, relatively low 
specimen volume  and disease stage have been described as possible factors affecting the 
sensitivity of blood culture (Wilson and Madigan 1989; Fecteau et al., 2009). In the present 
study, history of previous antimicrobial treatment was incomplete in some calves. 
Additionally, blood culture was always performed at admission and it is possible that not all 
calves were bacteremic at that time. More complete historical record collection is strongly 
recommended for further studies. 
 
Conclusions 
Plasma PCT measurements allow healthy calves to be differentiated from critically ill 
calves with clinical evidence of SIRS and septicemia. Further research could be performed to 
investigate the role of plasma PCT in reducing antimicrobial course length, as proposed in 
human medicine. Moreover, survival analysis using plasma PCT data should record the time 
to complete recovery, not just the final outcome. Finally, plasma PCT testing should be 
performed in calves with non-septic SIRS to better understand the role of this biomarker in 
the diagnosis of SIRS. 
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Ercan, N., Tuzcu, N., Başbug, O., Gok, K., Isidan, H., Ograk, Y.Z., 2014. The evaluation of 
important biomarkers in healthy cattle. Kafkas Üniversitesi Veteriner Fakültesi 
Dergisi 20(5), 749-755. 
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Figure legends 
 
Fig. 1. Box and whisker plot showing median and 10-90 percentiles for plasma procalcitonin 
(PCT) concentrations in the septic systemic inflammatory response syndrome (SIRS) group 
(n=58) and in the control group (n=20). *** P<0.0001. 
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Fig. 2. Receiver operating characteristic curve for the defined septic systemic inflammatory 
response syndrome analysis performed to obtain specificity and sensitivity of plasma 
procalcitonin at various cut-off values with a confidence interval of 95%. 
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Table 
Table 1. 
Receiver operating characteristic curve analysis data as assessed for the definition of the 
optimal cut-off value for plasma procalcitonin concentration to discriminate healthy calves 
from calves critically ill with clinical evidence of systemic inflammatory response syndrome 
and septicemia (n=78). 
 
Cut-off 
(pg/mL) 
Sensitivity 
% 
(95% CI)a 
Specificity % 
(95% CI) 
Likelihood 
ratio 
> 27.72 62 (35-85) 97 (85-100) 21.87 
> 32.82 69 (41-89) 97 (85-100) 24.06 
> 38.75 75 (48-93) 97 (85-100) 26.25 
> 55.60 81 (54-96) 97 (85-100) 28.44 
> 64.00 81 (69-90) 95 (73-100) 16.20 
> 67.39 81 (68-90) 100 (83-100) - 
> 70.09 81 (66-88) 100 (83-100) - 
a 95% CI, 95% Confidence interval 
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